PDT Partners’s Sangamo Therapeutics SGMO Stock Holding History

PDT Partners’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,915	Closed	-$284K	–	870
2022 Q3	$284K	Sell	57,915 -6,961	-11%	-$34.1K	0.04%	611
2022 Q2	$269K	Buy	64,876 +13,292	+26%	+$55.1K	0.02%	764
2022 Q1	$300K	Buy	51,584 +8,253	+19%	+$48K	0.03%	722
2021 Q4	$325K	Sell	43,331 -167,754	-79%	-$1.26M	0.02%	650
2021 Q3	$1.9M	Sell	211,085 -37,388	-15%	-$337K	0.14%	250
2021 Q2	$2.97M	Buy	248,473 +17,894	+8%	+$214K	0.2%	221
2021 Q1	$2.89M	Sell	230,579 -1,653	-0.7%	-$20.7K	0.21%	205
2020 Q4	$3.62M	Sell	232,232 -87,694	-27%	-$1.37M	0.24%	183
2020 Q3	$3.02M	Buy	319,926 +155,407	+94%	+$1.47M	0.2%	171
2020 Q2	$1.47M	Buy	+164,519	New	+$1.47M	0.1%	234
2020 Q1	–	Sell	-176,203	Closed	-$1.48M	–	837
2019 Q4	$1.48M	Sell	176,203 -54,425	-24%	-$456K	0.09%	224
2019 Q3	$2.09M	Buy	230,628 +267	+0.1%	+$2.42K	0.12%	200
2019 Q2	$2.48M	Buy	+230,361	New	+$2.48M	0.15%	165
2018 Q4	–	Sell	-196,212	Closed	-$3.33M	–	508
2018 Q3	$3.33M	Sell	196,212 -98,794	-33%	-$1.67M	0.14%	182
2018 Q2	$4.19M	Sell	295,006 -159,430	-35%	-$2.26M	0.16%	171
2018 Q1	$8.63M	Sell	454,436 -17,213	-4%	-$327K	0.29%	118
2017 Q4	$7.74M	Buy	+471,649	New	+$7.74M	0.22%	148
2017 Q2	–	Sell	-107,000	Closed	-$556K	–	563
2017 Q1	$556K	Buy	107,000 +21,600	+25%	+$112K	0.03%	367
2016 Q4	$260K	Sell	85,400 -47,000	-35%	-$143K	0.02%	447
2016 Q3	$613K	Buy	132,400 +300	+0.2%	+$1.39K	0.04%	353
2016 Q2	$765K	Buy	132,100 +19,500	+17%	+$113K	0.06%	288
2016 Q1	$681K	Buy	+112,600	New	+$681K	0.04%	367
2015 Q4	–	Sell	-79,216	Closed	-$447K	–	868
2015 Q3	$447K	Buy	79,216 +50,307	+174%	+$284K	0.01%	935
2015 Q2	$321K	Buy	+28,909	New	+$321K	0.01%	1114
2014 Q4	–	Sell	-33,294	Closed	-$359K	–	1030
2014 Q3	$359K	Buy	+33,294	New	+$359K	0.01%	1054
2013 Q3	–	Sell	-89,647	Closed	-$700K	–	1690
2013 Q2	$700K	Buy	+89,647	New	+$700K	0.02%	940